{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:18:48Z","timestamp":1790151528832,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejca.2013.12.003","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T21:38:56Z","timestamp":1388785136000},"page":"852-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions"],"prefix":"10.1016","volume":"50","author":[{"given":"Katharina","family":"Grupp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wilking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Prien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Sirma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bud\u00e4us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Izbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Schlomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Christina","family":"Tsourlakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2013.12.003_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2013.12.003_b0010","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1006\/bbrc.1997.7059","article-title":"Increased transcript level of RBM3, a member of the glycine-rich RNA-binding protein family, in human cells in response to cold stress","volume":"236","author":"Danno","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.12.003_b0015","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1242\/jcs.01026","article-title":"Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism","volume":"117","author":"Wellmann","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ejca.2013.12.003_b0020","first-page":"43","article-title":"A new generation of proto-oncogenes: cold-inducible RNA binding proteins","volume":"1805","author":"Lleonart","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejca.2013.12.003_b0025","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/hmg\/11.19.2279","article-title":"Modulation of polyglutamine-induced cell death by genes identified by expression profiling","volume":"11","author":"Kita","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejca.2013.12.003_b0030","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1038\/onc.2008.97","article-title":"Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe","volume":"27","author":"Sureban","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2013.12.003_b0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1203\/PDR.0b013e3181c13326","article-title":"The RNA-binding protein RBM3 is required for cell proliferation and protects against serum deprivation-induced cell death","volume":"67","author":"Wellmann","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ejca.2013.12.003_b0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/prca.201100020","article-title":"High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer","volume":"5","author":"Hjelm","year":"2011","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.ejca.2013.12.003_b0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1479-5876-8-78","article-title":"Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer","volume":"8","author":"Ehlen","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejca.2013.12.003_b0050","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/modpathol.2009.124","article-title":"Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer","volume":"22","author":"Jogi","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2013.12.003_b0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1479-5876-9-114","article-title":"Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmo Diet and Cancer Study","volume":"9","author":"Jonsson","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejca.2013.12.003_b0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1746-1596-6-91","article-title":"High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression","volume":"6","author":"Jonsson","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ejca.2013.12.003_b0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0302-2838(01)00021-5","article-title":"Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone","volume":"41","author":"Erbersdobler","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2013.12.003_b0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-60761-806-5_4","article-title":"Recipient block TMA technique","volume":"664","author":"Mirlacher","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ejca.2013.12.003_b0075","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1158\/1078-0432.CCR-11-1251","article-title":"ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy","volume":"17","author":"Minner","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2013.12.003_b0080","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/0008-5472.CAN-12-1342","article-title":"CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer","volume":"73","author":"Burkhardt","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.12.003_b0085","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/modpathol.2012.236","article-title":"Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions","volume":"26","author":"Kluth","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2013.12.003_b0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajpath.2012.04.026","article-title":"Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer","volume":"181","author":"Krohn","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2013.12.003_b0095","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1158\/0008-5472.CAN-07-0673","article-title":"Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis","volume":"67","author":"Lapointe","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.12.003_b0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2013.12.003_b0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09744","article-title":"The genomic complexity of primary human prostate cancer","volume":"470","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2013.12.003_b0110","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/modpathol.2008.104","article-title":"Clinical significance of p53 alterations in surgically treated prostate cancers","volume":"21","author":"Schlomm","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2013.12.003_b0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4","article-title":"Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy","volume":"178","author":"Bubendorf","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2013.12.003_b0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/modpathol.2012.206","article-title":"Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence","volume":"26","author":"Grupp","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2013.12.003_b0125","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejca.2013.12.003_b0130","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/0008-5472.CAN-10-0244","article-title":"FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells","volume":"70","author":"Gupta","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.12.003_b0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/1471-2407-11-507","article-title":"TMPRSS2-ERG-specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-beta signaling","volume":"11","author":"Brase","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2013.12.003_b0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1593\/neo.07822","article-title":"Role of the TMPRSS2-ERG gene fusion in prostate cancer","volume":"10","author":"Tomlins","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejca.2013.12.003_b0145","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1158\/1078-0432.CCR-09-1176","article-title":"Overexpression of prostate-specific TMPRSS2 (exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer","volume":"15","author":"Hermans","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491301068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491301068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T13:50:30Z","timestamp":1538920230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491301068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S095980491301068X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.12.003","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2013.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}